Back to Search
JONATHAN POSEY, PHARMD
PHARMD
Pharmacist
NPI: 1962852111Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
39711(TN)
Research & Publications (20)
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.
PMID 19652054·J Clin Oncol·2009
8-other
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
PMID 19406039·J Natl Compr Canc Netw·2009
6-review
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
PMID 19399502·Cancer Chemother Pharmacol·2009
3-trial
Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.
PMID 19104018·Antimicrob Agents Chemother·2009
8-other
Activity of sunitinib in patients with advanced neuroendocrine tumors.
PMID 18612155·J Clin Oncol·2008
3-trial
Multidetector computed tomography during combined therapy for pancreatic adenocarcinoma.
PMID 18585978·Clin Gastroenterol Hepatol·2008
6-review
Understanding how the V(D)J recombinase catalyzes transesterification: distinctions between DNA cleavage and transposition.
PMID 18375979·Nucleic Acids Res·2008
7-preclinical
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer.
PMID 17531105·Clin Colorectal Cancer·2007
3-trial
Target DNA structure plays a critical role in RAG transposition.
PMID 17105341·PLoS Biol·2006
7-preclinical
Hepatobiliary cancers. Clinical practice guidelines in oncology.
PMID 16948952·J Natl Compr Canc Netw·2006
6-review
Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis.
PMID 16452415·J Bacteriol·2006
8-other
Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study.
PMID 16317296·Anticancer Drugs·2006
3-trial
Phase 1 study of weekly polyethylene glycol-camptothecin in patients with advanced solid tumors and lymphomas.
PMID 16278410·Clin Cancer Res·2005
3-trial
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.
PMID 15838660·Cancer Chemother Pharmacol·2005
3-trial
PXR and the regulation of apoA1 and HDL-cholesterol in rodents.
PMID 15225665·Pharmacol Res·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1815 DECATUR PIKE
ATHENS, TN 37303 - Phone
- (423) 745-1495
Quick Facts
- NPI
- 1962852111
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile